SMOK-study: SSRI Medication in pregnant women: Effect on development of children.
Recruiting
- Conditions
- The use of SSRI by pregnant women.
- Registration Number
- NL-OMON22808
- Lead Sponsor
- n.a.
- Brief Summary
Planned: 4 manuscripts. One manuscript each on: otcome after 1 week; after 3 months; after 2 years; after 6 years.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 120
Inclusion Criteria
Newborn child exposed to an SSRI in utero.
Exclusion Criteria
Newborn child exposed to a non-SSRI antidepressant in utero.
Newborn child exposed to anti-epileptic drugs in utero.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method In the first week after birth and at 3 months post-term: Quality of general movements.<br>At the age of 2 years and 6 years: Motor and cognitive development.
- Secondary Outcome Measures
Name Time Method